Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

South Korean-Based Nature Cell Plans Baltimore City, Maryland, Production Operations

11/19/2025
South Korean-based biotechnology company Nature Cell plans to establish operations in Baltimore City, Maryland. The project is expected to create approximately 500 jobs.

The company’s new roughly 100,000-square-foot manufacturing facility, located at Gaslight Square, will initially focus on knee osteoarthritis and Alzheimer’s stem cell research, clinical trials, and manufacturing investigational products.

“We have chosen Maryland for the site of the Nature Cell Biostar USA Stem Cell Campus after a comprehensive evaluation of the state’s exceptional ecosystem for our business. Maryland offers an abundant pool of highly-skilled technical talent that is critical to establishing global leadership and setting industry standards in stem cell therapeutics,” said Nature Cell Chairman Dr. Jeong-Chan Ra. “The State of Maryland and Baltimore City also provide strong business support, including dedicated engagement from their government teams. Additionally, the region’s highly collaborative industry and academic network, anchored by world-class institutions such as Johns Hopkins University School of Medicine and its affiliated hospitals, are central to advancing stem cell research and development.”

To support the project the Maryland Department of Commerce is working to approve a $4 million conditional loan through Advantage Maryland. The Baltimore Development Corporation is providing a $400,000 conditional loan to assist the company with its operations, and Baltimore City will also assist in expediting permitting and public approvals for the project.

“Nature Cell will be an incredible addition to our state’s life sciences sector and will create hundreds of opportunities for our educated workforce,” noted Maryland Department of Commerce Secretary Harry Coker, Jr. “We thank the company for choosing Maryland for this new manufacturing facility and look forward to seeing its innovative progress in the years to come.”

Nature Cell does business in stem cells, cosmetics, and food and beverage development and manufacturing.

“Nature Cell America makes another excellent addition to the Carroll-Camden Industrial Area. This project shows how collaboration between the State of Maryland and the City of Baltimore delivers real results,” added Baltimore Development Corporation President and Chief Executive Officer Otis Rolley. “With the state’s Advantage Maryland program, BDC is providing a $400,000 conditional loan to support operations—we’re not only helping Nature Cell establish its U.S. presence, but also growing Baltimore’s biotech sector and creating quality jobs for city residents.”

Exclusive Research